Michael Gitman

2.5k total citations
11 papers, 114 citations indexed

About

Michael Gitman is a scholar working on Pulmonary and Respiratory Medicine, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Michael Gitman has authored 11 papers receiving a total of 114 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pulmonary and Respiratory Medicine, 2 papers in Infectious Diseases and 2 papers in Molecular Biology. Recurrent topics in Michael Gitman's work include Electrolyte and hormonal disorders (2 papers), SARS-CoV-2 and COVID-19 Research (1 paper) and HIV Research and Treatment (1 paper). Michael Gitman is often cited by papers focused on Electrolyte and hormonal disorders (2 papers), SARS-CoV-2 and COVID-19 Research (1 paper) and HIV Research and Treatment (1 paper). Michael Gitman collaborates with scholars based in United States, United Kingdom and Germany. Michael Gitman's co-authors include Pravin C. Singhal, Amit Kumar Dinda, David Hirschwerk, Kenar D. Jhaveri, Bodo B. Beck, John A. Sayer, Friedhelm Hildebrandt, Howard Trachtman, Anne Baasner and Matthias T. F. Wolf and has published in prestigious journals such as The American Journal of Gastroenterology, International Journal of Environmental Research and Public Health and American Journal of Kidney Diseases.

In The Last Decade

Michael Gitman

11 papers receiving 109 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael Gitman United States	5	33	24	23	20	16	11	114
Pardis Ziaeefar Iran	6	11 0.3×	8 0.3×	11 0.5×	14 0.7×	5 0.3×	17	73
Vishwanath Biradar Australia	5	11 0.3×	27 1.1×	16 0.7×	8 0.4×	6 0.4×	9	116
Preetam Arthur India	6	20 0.6×	26 1.1×	15 0.7×	72 3.6×	9 0.6×	20	260
A Checoury France	7	31 0.9×	33 1.4×	34 1.5×	30 1.5×	6 0.4×	14	164
F. J. Lang Austria	4	30 0.9×	14 0.6×	12 0.5×	5 0.3×	5 0.3×	7	76
Georg Hillebrand Germany	6	7 0.2×	23 1.0×	25 1.1×	15 0.8×	8 0.5×	11	138
Paloma Oliver Spain	7	16 0.5×	15 0.6×	9 0.4×	4 0.2×	15 0.9×	33	109
M. Christiaans Netherlands	4	16 0.5×	10 0.4×	13 0.6×	58 2.9×	9 0.6×	5	199
Fabian Meienberg Switzerland	8	100 3.0×	46 1.9×	25 1.1×	7 0.3×	7 0.4×	17	277
Ana Marta Gomes Portugal	7	6 0.2×	27 1.1×	31 1.3×	5 0.3×	37 2.3×	30	151

Countries citing papers authored by Michael Gitman

Since Specialization

Citations

This map shows the geographic impact of Michael Gitman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Gitman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Gitman more than expected).

Fields of papers citing papers by Michael Gitman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Gitman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Gitman. The network helps show where Michael Gitman may publish in the future.

Co-authorship network of co-authors of Michael Gitman

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Gitman. A scholar is included among the top collaborators of Michael Gitman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Gitman. Michael Gitman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Brune, Zarina, Cyrus E. Kuschner, Karina W. Davidson, et al.. (2021). Effectiveness of SARS-CoV-2 Decontamination and Containment in a COVID-19 ICU. International Journal of Environmental Research and Public Health. 18(5). 2479–2479. 3 indexed citations

Gitman, Michael, Alessandro Bellucci, & Steven Fishbane. (2018). Administrative Leadership: Nephrologists in Non-nephrology Leadership Roles. Advances in Chronic Kidney Disease. 25(6). 490–493. 1 indexed citations

Gitman, Michael, et al.. (2012). Ranolazine, Tacrolimus, and Diltiazem Might be a Hazardous Combination in a Transplant Patient. Renal Failure. 34(2). 251–253. 2 indexed citations

Gitman, Michael, et al.. (2012). Long Term Effects of 5-Aminosalicyclic Acid Use on Renal function in the Elderly with Inflammatory Bowel Disease. The American Journal of Gastroenterology. 107. S635–S635. 1 indexed citations

Beck, Bodo B., Howard Trachtman, Michael Gitman, et al.. (2011). Autosomal Dominant Mutation in the Signal Peptide of Renin in a Kindred With Anemia, Hyperuricemia, and CKD. American Journal of Kidney Diseases. 58(5). 821–825. 20 indexed citations

Jhaveri, Kenar D., et al.. (2010). Severe hyperkalaemia resulting from octreotide use in a haemodialysis patient. Nephrology Dialysis Transplantation. 25(10). 3439–3442. 8 indexed citations

Gitman, Michael, et al.. (2007). Tenofovir-induced kidney injury. Expert Opinion on Drug Safety. 6(2). 155–164. 34 indexed citations

Storch, Ian, et al.. (2007). Metastatic Melanoma in a Dialysis Patient with Vomiting Diagnosed by Gastric Polyp Biopsy. The American Journal of Gastroenterology. 102. S343–S343. 2 indexed citations

Ashfaq, Akhtar, Michael Gitman, & Pravin C. Singhal. (2006). Emerging strategies for lowering serum phosphorous in patients with end-stage renal disease. Expert Opinion on Pharmacotherapy. 7(14). 1897–1905. 1 indexed citations

10.

Dinda, Amit Kumar, Michael Gitman, & Pravin C. Singhal. (2005). Immunomodulatory effect of morphine: therapeutic implications. Expert Opinion on Drug Safety. 4(4). 669–675. 26 indexed citations

11.

Gitman, Michael & Pravin C. Singhal. (2004). Cocaine-induced renal disease. Expert Opinion on Drug Safety. 3(5). 441–448. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact